Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia

Bhatt Deepak L.; Steg P. Gabriel; Miller Michael; Brinton Eliot A.; Jacobson Terry A.; Ketchum Steven B.; Doyle Ralph T. Jr.; Juliano Rebecca A.; Jiao Lixia; Granowitz Craig; Tardif Jean-Claude; Ballantyne Christie M.

首页> 外文期刊>The New England journal of medicine >Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia

【24h】

Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia

机译：用icosapent乙基用于高糖苷蛋白血症的心血管风险降低

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

BACKGROUND

机译：背景

著录项

来源
《The New England journal of medicine》 |2019年第1期|共12页
作者
Bhatt Deepak L.; Steg P. Gabriel; Miller Michael; Brinton Eliot A.; Jacobson Terry A.; Ketchum Steven B.; Doyle Ralph T. Jr.; Juliano Rebecca A.; Jiao Lixia; Granowitz Craig; Tardif Jean-Claude; Ballantyne Christie M.;
展开▼
作者单位

Brigham &

Womens Hosp Heart &

Vasc Ctr 75 Francis St Boston MA 02115 USA;

Univ Paris Diderot Hop Bichat AP HP INSERM U1148 FACT Dept Hosp Univ FIRE Fibrose Inflammat &

Univ Maryland Sch Med Dept Med Baltimore MD 21201 USA;

Utah Lipid Ctr Salt Lake City UT USA;

Emory Univ Sch Med Dept Med Off Hlth Promot &

Dis Prevent Atlanta GA USA;

Amarin Pharma Bedminster NJ USA;

Amarin Pharma Bedminster NJ USA;

Amarin Pharma Bedminster NJ USA;

Amarin Pharma Bedminster NJ USA;

Amarin Pharma Bedminster NJ USA;

Univ Montreal Montreal Heart Inst Montreal PQ Canada;

Baylor Coll Med Dept Med Houston TX 77030 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类 R23;
关键词

相似文献

外文文献
中文文献
专利

1. Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia [J] . Bhatt Deepak L., Steg P. Gabriel, Miller Michael, The New England journal of medicine . 2019,第1期

机译：用icosapent乙基用于高糖苷蛋白血症的心血管风险降低
2. Spotlight on Icosapent Ethyl for Cardiovascular Risk Reduction: Evidence to Date [J] . Xiaoming Jia, Stephanie Koh, Mahmoud Al Rifai, Vascular Health and Risk Management . 2020,第1期

机译：射灯对icosapent ethyl进行心血管风险减少：迄今为止的证据
3. Cardiovascular Risk Reduction with Icosapent Ethyl REPLY [J] . Bhatt Deepak L., Steg P. Gabriel, Miller Michael The New England journal of medicine . 2019,第17期

机译：用icosapent乙基回复减少心血管风险
4. Past, present, and future clinical trials ofcardiovascular risk reduction-thehypertension perspective [C] . International Symposium on Atherosclerosis . 2004

机译：过去，现在和未来的心血管风险降低临床试验 - 高血压视角
5. The relation of cardiovascular disease risk factors to intent to participate in cardiovascular disease risk reduction options in a worksite population. [D] . Vana, Joyce E. 1991

机译：心血管疾病危险因素与参与工作场所人群减少心血管疾病风险的意愿的关系。
6. The Novelty of Icosapent Ethyl in the Management of Hypertriglyceridemia and Alleviating Cardiovascular Risk [O] . Muhammad Shoaib Khan, Muhammad Ishaq, Muhammad Talha Ayub, 2021

机译：高甘油三酯血症管理中icosapent乙基的新颖性缓解心血管风险
7. The Novelty of Icosapent Ethyl in the Management of Hypertriglyceridemia and Alleviating Cardiovascular Risk [O] . Muhammad Shoaib Khan, Muhammad Ishaq, Muhammad Talha Ayub, 2021

机译：高甘油三酯血症管理中icosapent乙基的新颖性，缓解心血管风险

Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅